{
    "2021-01-27": [
        [
            {
                "time": "2020-12-31",
                "original_text": "沃森生物：2020年预计净利润同比增长590.0%~620.0%",
                "features": {
                    "keywords": [
                        "沃森生物",
                        "净利润",
                        "同比增长",
                        "590%",
                        "620%"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-12-31",
                "original_text": "沃森生物：预计2020年实现净利润9.8亿元-10.22亿元 同比增长590%-620%",
                "features": {
                    "keywords": [
                        "沃森生物",
                        "净利润",
                        "9.8亿元",
                        "10.22亿元",
                        "同比增长",
                        "590%",
                        "620%"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-12-31",
                "original_text": "沃森生物(300142.SZ)预计2020年度归母净利润同比增长590%至620%",
                "features": {
                    "keywords": [
                        "沃森生物",
                        "归母净利润",
                        "同比增长",
                        "590%",
                        "620%"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-12-31",
                "original_text": "沃森生物：预计2020年盈利9.8亿元-10.22亿元，同比增长590%-620%",
                "features": {
                    "keywords": [
                        "沃森生物",
                        "盈利",
                        "9.8亿元",
                        "10.22亿元",
                        "同比增长",
                        "590%",
                        "620%"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-12-31",
                "original_text": "沃森生物：预计2020年度净利9.80亿元-10.22亿元，同比增长590%-620%",
                "features": {
                    "keywords": [
                        "沃森生物",
                        "净利",
                        "9.80亿元",
                        "10.22亿元",
                        "同比增长",
                        "590%",
                        "620%"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-12-31",
                "original_text": "沃森生物：2020年净利预增590%-620%",
                "features": {
                    "keywords": [
                        "沃森生物",
                        "净利",
                        "预增",
                        "590%",
                        "620%"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-12-31",
                "original_text": "沃森生物现1笔大宗交易 共成交920.46万元",
                "features": {
                    "keywords": [
                        "沃森生物",
                        "大宗交易",
                        "920.46万元"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}